Top Stories
Over the last several months, the startup has grown its revenue five-fold, added more than 40 healthcare customers and expanded across over 150,000 healthcare providers.
Partnership aims to discover and develop candidates for neuroimmune disorders with an unmet need.
The company's Body Scan scale measures fat and muscle mass percentages, giving obesity care teams more insight into a patient's health than just their weight.
Physician reviewers have assessed more than 700,000 example responses as the company works to improve how ChatGPT handles medical uncertainty.
The deal gives Takeda's discovery teams direct access to Boltz's newest biomolecular foundation models, including BoltzMol-1 and BoltzProt-1.
Conference News
Showcasing how advanced AI models are transforming clinical development and accelerating precision medicineWALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene, leading developer of AI models for tumor and im...
ASCO Perspective Quote“Prior studies on multi-cancer early detection tests have largely focused on Western populations. This large-scale study across 6 Asian countries showed the potential for cell-fr...
SEC-registered, FINRA-member platform expands capital access for life science innovatorsSAN DIEGO, CA, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- BioTech Social Inc. (BSI) today announced the ...
Company to present data demonstrating increases in CSF HDL-like lipid transport proteins following Spectris™ therapyCAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cognito Therapeutics, a clinical-stage neurotech...
Key facts:Expanding advanced manufacturing capacity and services: Recent investments in biologics, sterile fill-finish, oral solid dose manufacturing and integrated device assembly strengthen Thermo ...
